Blogs

Jul 16, 2018
Applied Clinical Trials
In this interview, Jim Streeter, Global Vice President of Life Sciences Product Strategy at Oracle, will elaborate further on Oracle’s strategy with mHealth in clinical trials.
Jul 16, 2018
Applied Clinical Trials
The question is, how much attention should be paid to historical recruitment figures if the team only reviews the data from one (or two) similar studies?
Jul 12, 2018
Applied Clinical Trials
In this interview, Linda Rawlings, VP of Neurodegenerative Development at Synteract, elaborates on addressing the challenges of neurodegenerative disease clinical trials.
Jul 11, 2018
Applied Clinical Trials
Patients stand to lose the most when sponsors hold too tightly to drugs doomed to fail. This wastes precious time that patients don’t have and squanders valuable resources.
Jul 11, 2018
Applied Clinical Trials
Given the rapid changes in the communication landscape brought about by participative Internet use and social media, it is important to develop a better understanding of these technologies and their impact on health communication.
Jul 01, 2018
Applied Clinical Trials
Recent developments offer more clues to the EU’s seemingly less-than-serious approach to health policy formation.
Jul 01, 2018
Applied Clinical Trials
Although Biogen's Alzheimer's drug candidate BAN2401 addresses buildup of amyloid plaques, investors and scientists look to reevaluate the plaque theory and search for a glimmer of hope in breakthrough treatments.
Jul 01, 2018
Applied Clinical Trials
FDA is testing various strategies to streamline research and regulatory oversight by looking to novel clinical trial designs to advance new treatments.
Jun 26, 2018
Applied Clinical Trials
The late-June announcement that Ireland is joining the Beneluxa Initiative on Pharmaceutical Policy might suggest renewed vigour for the drive to equip national governments with more clout in their pricing negotiations with international drug firms.
Jun 25, 2018
Applied Clinical Trials
The general assumption that the Policy 0070 data releases were public data releases can be challenged since there is a mechanism to enforce the ToU, and this mechanism will continue to exist after the Agency moves to the Netherlands.
native1_300x100
lorem ipsum